Existence of dopamine D1 receptor on the sympathetic nerve endings in the guinea-pig vas deferens

European Journal of Pharmacology

Volumn 328, Issue 2-3, 1997, Pages 229-234

  Furukawa, Tatsuo ^a   Morishita, Hideji ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

ATP; Dopamine D1 receptor; Neurotransmission; Vas deferens, guinea pig; 2 Adrenoceptor

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE TRIPHOSPHATE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; BRIMONIDINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; IDAZOXAN; NORADRENALIN; PRESYNAPTIC RECEPTOR; PURINE P2X RECEPTOR; SPIPERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA,BETA-METHYLENEADENOSINE 5'-TRIPHOSPHATE; BENZAZEPINE DERIVATIVE; DRUG DERIVATIVE; QUINOXALINE DERIVATIVE; SK&F 82958;

ADRENERGIC TRANSMISSION; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SELECTIVITY; ELECTROSTIMULATION; GUINEA PIG; MALE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SYMPATHETIC NERVE; VAS DEFERENS; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; IN VITRO STUDY; MUSCLE CONTRACTION; SMOOTH MUSCLE; SYNAPTIC TRANSMISSION; SYNAPTOSOME;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ADENOSINE TRIPHOSPHATE; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BENZAZEPINES; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION; GUINEA PIGS; IDAZOXAN; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PRESYNAPTIC TERMINALS; QUINOXALINES; RECEPTORS, DOPAMINE D1; SPIPERONE; SYNAPTIC TRANSMISSION; VAS DEFERENS;

EID: 0030610128     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)83049-X     Document Type: Article

References (35)

1. Allcorn R.J., Cunnane T.C., Kirkpatrick K. Actions of α,β-methylene ATP and 6-hydroxydopamine on sympathetic neurotransmission in the vas deferens of the guinea-pig, rat and mouse: support for co-transmission. Br. J. Pharmacol. 89:1986;647-659.
2. 1 receptor efficacy. Eur. J. Pharmacol. 188:1990;335-347.
3. Badia A., Bermejo P., Jané F. Pre- and postsynaptic effects of sulpiride in the rat isolated vas deferens. J. Pharm. Pharmacol. 34:1982;266-268.
4. Bell C. Effects of dopamine on adrenergic neuromuscular transmission in the guinea-pig vas deferens. Br. J. Pharmacol. 68:1980;505-512.
5. Bell C., Matalanis G. Dopamine-induced depression of adrenergic nerve-mediated contraction of smooth muscle. Br. J. Pharmacol. 61:1977;291-295.
6. Burnstock G. Noradrenaline and ATP as cotransmitters in sympathetic nerves. Neurochem. Int. 17:1990;357-368.
7. Burnstock G., Holman M.E. An electrophysiological investigation of the actions of some autonomic blocking drugs on transmission in the guinea-pig vas deferens. Br. J. Pharmacol. 23:1964;600-612.
8. Castelli M., Genedani S. Phentolamine inhibition of rat seminal vesicle response to dopamine-mimetic drugs: α-adrenoceptor implication or lack of specificity? J. Pharm. Pharmacol. 34:1982;331-333.
9. 2-adrenoceptors. Br. J. Pharmacol. 78:1983;489-505.
10. Doxey J.C., Lane A.C., Roach A.G., Virdee N.K. Comparison of the α-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine. Naunyn-Schmiedeberg's Arch. Pharmacol. 325:1984;136-144.
11. 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue. Biochem. Pharmacol. 38:1989;473-480.
12. Fedan J.S., Hogaboom G.K., O'Donnell J.P., Colby J., Westfall D.P. Contribution by purines to the neurogenic response of the vas deferens of the guinea pig. Eur. J. Pharmacol. 69:1981;41-53.
13. Galitzky J., Mauriege P., Berlan M., Lafontan M. Human fat cell alpha-2 adrenoceptors. 1. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists J. Pharmacol. Exp. Ther. 249:1989;583-591.
14. Gibson A., Samini M. The effects of bromocriptine on pre-synaptic and post-synaptic α-adrenoceptors in the mouse vas deferens. J. Pharm. Pharmacol. 31:1979;826-830.
15. Grant J.A., Scrutton M.C. Interaction of selective α-adrenoceptor agonist and antagonists with human and rabbit blood platelets. Br. J. Pharmacol. 71:1980;121-134.
16. Hurst M.J., Marshall I., Nasmyth P.A. Dopamine inhibition of the twitch response of the mouse isolated vas deferens. Br. J. Pharmacol. 66:1979;131.
17. 2-adrenoceptors and presynaptic dopamine receptors using field stimulated right cat atria. Eur. J. Pharmacol. 88:1983;311-317.
18. Langer S.Z. Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 32:1981;337-362.
19. Leedham J.A., Pennefather J.N. Dopamine acts at the same receptors as noradrenaline in the rat isolated vas deferens. Br. J. Pharmacol. 77:1982;293-299.
20. Lew M.J., White T.D. Release of endogenous ATP during sympathetic nerve stimulation. Br. J. Pharmacol. 92:1987;349-355.
21. McGrath J.C. Adrenergic and 'non-adrenergic' components in the contractile response of the vas deferens to a single indirect stimulus. J. Physiol. (London). 283:1978;23-39.
22. Meldrum L.A., Burnstock G. Evidence that ATP acts as a co-transmitter with noradrenaline in sympathetic nerves supplying the guinea-pig vas deferens. Eur. J. Pharmacol. 92:1983;161-163.
23. Morishita H., Sugiyama M., Furukawa T. Inhibition by sulfur-containing amino acids and GABA of sympathetic neurotransmission in guinea-pig vas deferens. Eur. J. Pharmacol. 95:1983;13-19.
24. 3H]clonidine binding. Mol. Pharmacol. 35:1989;345-354.
25. Sibley D.R., Monsma F.J. Jr. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13:1992;61-69.
26. 2 Dopamine Receptor Interactions. Academic Press, London, pp. 1-21.
27. Sneddon P., Burnstock G. Inhibition of excitatory junction potentials in guinea-pig vas deferens by α,β-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters. Eur. J. Pharmacol. 100:1984;85-90.
28. Sneddon P., Westfall D.P., Fedan J.S. Cotransmitters in the motor nerves of the guinea pig vas deferens: electrophysiological evidence. Science. 218:1982;693-695.
29. Sokoloff P., Schwartz J.C. Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16:1995;270-275.
30. Starke K., Göthert M., Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev. 69:1989;864-989.
31. Swedin G. Biphasic mechanical response of the isolated vas deferens to nerve stimulation. Acta Physiol. Scand. 81:1971;574-576.
32. Tayo F.M. Prejunctional inhibitory α-adrenoceptors and dopaminoceptors of the rat vas deferens and the guinea-pig ileum in vitro. Eur. J. Pharmacol. 58:1979;189-195.
33. Tayo F.M. Prejunctional inhibitory dopamine receptors in the rat isolated vas deferens. Arch. Int. Pharmacodyn. 254:1981;28-37.
34. Westfall D.P., Stitzel R.E., Rowe J.N. The postjunctional effects and neural release of purine compounds in the guinea-pig vas deferens. Eur. J. Pharmacol. 50:1978;27-38.
35. Willems J.L., Buylaert W.A., Lefebvre R.A., Bogaert M.G. Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system. Pharmacol. Rev. 37:1985;165-216.